This article is more than 5 years old. Information may no longer be current.

VIDEO: Loading dose of secukinumab affects outcomes in PsA

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN DIEGO – Secukinumab may be an effective treatment for patients with psoriatic arthritis, according to findings presented at the American College of Rheumatology Annual Meeting.

Eric M. Ruderman, MD, professor of medicine at Northwestern University’s Feinberg School of Medicine, describes the trial design and the results. The study included one arm that was not treated with a loading dose and two arms that were.

Patients who did not receive a loading dose “didn’t seem to do as well” as patients who did, which suggests that treatment with a loading dose “is the appropriate way to use this medication in clinical practice,” according to Ruderman.